title: [Activity of selected neutrophil enzymes of patients maintained on hemodialysis and treated with erythropoietin (rHu EPO)].
abstract: The peroxidase, alkaline phosphatase, acid phosphatase, beta-glucuronidase and N-acetyl-beta-D-glucosaminidase activity was assessed using a semiquantitative cytochemical methods in peripheral blood neutrophils from 10 maintenance haemodialysed patients treated with recombinant human erythropoietin (rHu EPO) due to severe anaemia. The examination was performed immediately prior to rHu EPO treatment, after 10 weeks and 32 weeks of therapy. A statistically significant increase in the beta-glucuronidase and N-acetyl-beta-D-glucosaminidase activity was observed after 10 weeks, while all the enzymes studied except peroxidase showed a significant elevation of their activity after 32 weeks of the treatment as compared with the values obtained prior to therapy.
authors.affiliation: Kliniki Nefrologii AM w Krakowie.
authors.forename: W
authors.initials: W
authors.lastname: Sułowicz
authors.forename: Z
authors.initials: Z
authors.lastname: Hanicki
authors.forename: J
authors.initials: J
authors.lastname: Lisiewicz
authors.forename: A
authors.initials: A
authors.lastname: Kopeć
authors.forename: A
authors.initials: A
authors.lastname: Kraśniak
authors.forename: M
authors.initials: M
authors.lastname: Kuźniewski
authors.forename: J
authors.initials: J
authors.lastname: Kopeć
authors.forename: A
authors.initials: A
authors.lastname: Sydor
mesh_terms: D000328:Adult; D000740:Anemia / Q000097:blood / Q000209:etiology / Q000628:therapy*; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009504:Neutrophils / Q000201:enzymology*; D011994:Recombinant Proteins / Q000627:therapeutic use; D006435:Renal Dialysis
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin
vernacular_title: Aktywność wybranych enzymów neutrofilów chorych przewlekle dializowanych leczonych erytropoetyna (rHu EPO).